Ratio of earnings before interest, taxes, depreciation, and amortization to sales for private limited companies in the pharmaceuticals and medicines manufacturing industry
Annual · percent · 2010–2012 · Published by India — Reserve Bank of India
Latest · 2012
13.3%
down −1.5 pts vs 2011
- High since 2010
- 14.8% · 2011
- Low since 2010
- 12.7% · 2010
percent
Use this series in your AI
Use FactIQ to chart rbi::rbi|02c575150f3848f9 over the last ten years, with its latest value and the change over the past year.
The same rows through the SQL tool of the FactIQ plugin or MCP connector.
SELECT time, value
FROM rbi.data_points
WHERE series_id = 'rbi|02c575150f3848f9'
ORDER BY time;About this series
This series represents the EBITDA to sales ratio, a key profitability metric, for non-government non-financial private limited companies operating within the pharmaceuticals and medicines subgroup of the manufacturing sector. The data is derived from financial ratios of select items for the 2012-13 fiscal year snapshot. (Footnote: Note : 1. Figures in brackets below the industry name represent the number of companies in the industry. 2. For footnotes, please refer to Statement 2 and Statement 7. 3. Industry group, viz., 'Basic Chemicals' and 'Pharmaceuticals & Medicines' are subgroup of 'Chemical and Chemical Products'. 4. Industry group, viz., 'Plastic Products' is the subgroup of 'Rubber and Plastic Products'.)
- Series ID
- rbi::rbi|02c575150f3848f9
- Frequency
- Annual
- Units
- percent
- Coverage
- 2010 – 2012